PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
about
Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASHLetter: gender-associated cell-free microRNA profiles in non-alcoholic fatty liver disease.Berberis vulgaris extract/β-cyclodextrin complex increases protection of hepatic cells via suppression of apoptosis and lipogenesis pathways.18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulationDonor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational StudyPromoter methylation status and expression of PPAR-γ gene are associated with prognosis of acute-on-chronic hepatitis B liver failureCurrent role of fenofibrate in the prevention and management of non-alcoholic fatty liver diseaseMicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.Protein-protein interaction network analysis of cirrhosis liver disease.Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Peroxisome proliferator activating receptor-γ and the podocyte.Gamma-Glutamylcysteine Ethyl Ester Protects against Cyclophosphamide-Induced Liver Injury and Hematologic Alterations via Upregulation of PPARγ and Attenuation of Oxidative Stress, Inflammation, and Apoptosis.Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation.Brown seaweeds protect against azoxymethane-induced hepatic repercussions through up-regulation of peroxisome proliferator-activated receptor gamma and attenuation of oxidative stress.MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ.
P2860
Q26778376-D3036499-8928-4C63-8DE1-4D26D47EED0DQ33555429-31F5583E-A100-4DBD-8A24-EC8A91C4D790Q33724172-1A03027A-4DB8-42EF-9CCE-D62D9DF92E92Q36074465-71835C67-237B-4EEF-BB1E-A4BCC374A588Q36194349-E48D4046-2F3E-4215-B8A2-1681993FC319Q36224015-CDF20A5E-ED8C-4BD9-8DE0-B926E168B908Q37196514-686B5975-B742-4FDB-BCD2-A22BDDF641B3Q37607478-670B79BA-B858-4F2E-BCB1-1BC005F62BEFQ38448298-EF40600D-5C85-4A15-9D76-E03E028052F7Q38711627-3E78D9A0-A4D8-40E7-B54A-9CE071442F01Q38752520-7609116B-4B61-4450-9577-B9A534BADCB4Q38815188-033E5003-A7F1-4181-AF72-CC217C854EA3Q39028144-5E7F44FA-7A4C-4506-99EF-B55EBFB3A32AQ46390723-C06B900D-5D6D-4113-B5BC-8900724AB0D6Q48511010-3B70CB23-3532-4670-B197-D19CB222210CQ53651758-2604CE07-822A-4FCE-A81A-896BBC1AEFDC
P2860
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
@ast
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
@en
type
label
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
@ast
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
@en
prefLabel
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
@ast
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
@en
P2093
P2860
P356
P1433
P1476
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
@en
P2093
Lucie Bourgoin
Marion Peyrou
Michelangelo Foti
Pierluigi Ramadori
P2860
P304
P356
10.1155/2012/757803
P577
2012-09-13T00:00:00Z